PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis

Science Translational Medicine

Volumn 6, Issue 265, 2014, Pages

  Chen, Ray Y ^a   Dodd, Lori E ^a   Lee, Myungsun ^b   Paripati, Praveen ^c   Hammoud, Dima A ^d   Mountz, James M ^e   Jeon, Doosoo ^f   Zia, Nadeem ^e   Zahiri, Homeira ^d   Coleman, M Teresa ^e   Carroll, Matthew W ^a   Lee, Jong Doo ^g   Jeong, Yeon Joo ^h   Herscovitch, Peter ^d   Lahouar, Saher ^c   Tartakovsky, Michael ^a   Rosenthal, Alexander ^a   Somaiyya, Sandeep ^c   Lee, Soyoung ^b   Goldfeder, Lisa C ^a   Cai, Ying ^a   Via, Laura E ^a   Park, Seung Kyu ^f   Cho, Sang Nae ^b,g   Barry, Clifton E ^a,i   more..

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b International Tuberculosis Research Center   (South Korea)

^c NET Esolutions Corporation (NETE) NETE FGI Imaging Team   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f Masan National Hospital   (South Korea)

^g Yonsei University College of Medicine   (South Korea)

^h Pusan National University School of Medicine   (South Korea)

ⁱ UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METRONIDAZOLE; PLACEBO; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE MARKER; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; OUTCOME ASSESSMENT; PREDICTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SPUTUM CULTURE; TREATMENT DURATION; TREATMENT OUTCOME; ALGORITHM; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; DIAGNOSTIC USE; LUNG; MICROBIOLOGY; MULTIMODAL IMAGING; OBSERVER VARIATION; PHASE 2 CLINICAL TRIAL; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ADULT; ALGORITHMS; DOUBLE-BLIND METHOD; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG; MALE; METRONIDAZOLE; MULTIMODAL IMAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; ROC CURVE; SENSITIVITY AND SPECIFICITY; SOFTWARE; SPUTUM; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84915746502     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009501     Document Type: Article

References (46)

1. R. S. Wallis, P. Kim, S. Cole, D. Hanna, B. B. Andrade, M. Maeurer, M. Schito, A. Zumla, Tuberculosis biomarkers discovery: Developments, needs, and challenges. Lancet Infect. Dis. 13, 362-372 (2013).
2. D. J. Horne, S. E. Royce, L. Gooze, M. Narita, P. C. Hopewell, P. Nahid, K. R. Steingart, Sputum monitoring during tuberculosis treatment for predicting outcome: Systematic review and meta-analysis. Lancet Infect. Dis. 10, 387-394 (2010).
3. D. Benator, M. Bhattacharya, L. Bozeman, W. Burman, A. Cantazaro, R. Chaisson, F. Gordin, C. R. Horsburgh, J. Horton, A. Khan, C. Lahart, B. Metchock, C. Pachucki, L. Stanton, A. Vernon, M. E. Villarino, Y. C. Wang, M. Weiner, S. Weis, C. Tuberculosis Trials, Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: A randomised clinical trial. Lancet 360, 528-534 (2002).
4. J. L. Johnson, D. J. Hadad, R. Dietze, E. L. Maciel, B. Sewali, P. Gitta, A. Okwera, R. D. Mugerwa, M. R. Alcaneses, M. I. Quelapio, T. E. Tupasi, L. Horter, S. M. Debanne, K. D. Eisenach, W. H. Boom, Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion. Am. J. Respir. Crit. Care Med. 180, 558-563 (2009).
5. P. P. Phillips, A. J. Nunn, N. I. Paton, Is a 4-month regimen adequate to cure patients with non-cavitary tuberculosis and negative cultures at 2 months? Int. J. Tuberc. Lung Dis. 17, 807-809 (2013).
6. P. P. Phillips, K. Fielding, A. J. Nunn, An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapse. PLOS One 8, e63840 (2013).
7. H. Kato, M. Nakajima, The efficacy of FDG-PET for the management of esophageal cancer: Review article. Ann. Thorac. Cardiovasc. Surg. 18, 412-419 (2012).
8. T. D. Poeppel, B. J. Krause, T. A. Heusner, C. Boy, A. Bockisch, G. Antoch, PET/CT for the staging and follow-up of patients with malignancies. Eur. J. Radiol. 70, 382-392 (2009).
9. G. Xu, L. Zhao, Z. He, Performance of whole-body PET/CT for the detection of distant malignancies in various cancers: A systematic review and meta-analysis. J. Nucl. Med. 53, 1847-1854 (2012).
10. N. S. Paul, S. Ley, U. Metser, Optimal imaging protocols for lung cancer staging: CT, PET, MR imaging, and the role of imaging. Radiol. Clin. North Am. 50, 935-949 (2012).
11. D. E. Maziak, G. E. Darling, R. I. Inculet, K. Y. Gulenchyn, A. A. Driedger, Y. C. Ung, J. D. Miller, C. S. Gu, K. J. Cline, W. K. Evans, M. N. Levine, Positron emission tomography in staging early lung cancer: A randomized trial. Ann. Intern. Med. 151, 221-228 (2009).
12. M. L. Margolis, The PET and the pendulum. Ann. Intern. Med 151, 279-280 (2009).
13. M. T. Truong, R. F. Munden, B. Movsas, Imaging to optimally stage lung cancer: Conventional modalities and PET/CT. J. Am. Coll. Radiol. 1, 957-964 (2004).
14. M. Sathekge, A. Maes, M. Kgomo, A. Stoltz, H. Pottel, C. Van de Wiele, Impact of FDG PET on the management of TBC treatment. A pilot study. Nuklearmedizin 49, 35-40 (2010).
15. S. K. Heysell, T. A. Thomas, C. D. Sifri, P. K. Rehm, E. R. Houpt, 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: A case series. BMC Pulm. Med. 13, 14 (2013).
16. A. Hofmeyr, W. F. Lau, M. A. Slavin, Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response. Tuberculosis 87, 459-463 (2007).
17. J. M. Goo, J. G. Im, K. H. Do, J. S. Yeo, J. B. Seo, H. Y. Kim, J. K. Chung, Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases. Radiology 216, 117-121 (2000).
18. 18F-FDG PET/CT: Report of three cases. World J. Gastroenterol. 16, 4237-4242 (2010).
19. 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis. Eur. J. Nucl. Med. Mol. Imaging 36, 632-639 (2009).
20. 18F-FDG PET-CT for determination of pulmonary tuberculoma activity. Eur. J. Nucl. Med. Mol. Imaging 35, 808-814 (2008).
21. 18F-FDG PET/CT in tuberculosis: An early non-invasive marker of therapeutic response. Int. J. Tuberc. Lung Dis. 16, 1180-1185 (2012).
22. 18F-FDG PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis. J. Nucl. Med. 52, 880-885 (2011).
23. I. N. Park, J. S. Ryu, T. S. Shim, Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography. Clin. Nucl. Med. 33, 1-3 (2008).
24. G. Tian, Y. Xiao, B. Chen, J. Xia, H. Guan, Q. Deng, FDG PET/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis. Acta Radiol. 51, 1002-1006 (2010).
25. Y. H. Wang, A. S. Lin, Y. F. Lai, T. Y. Chao, J. W. Liu, S. F. Ko, The high value of high-resolution computed tomography in predicting the activity of pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 7, 563-568 (2003).
26. N. Kosaka, T. Sakai, H. Uematsu, H. Kimura, M. Hase, M. Noguchi, H. Itoh, Specific high-resolution computed tomography findings associated with sputum smear-positive pulmonary tuberculosis. J. Comput. Assist. Tomogr. 29, 801-804 (2005).
27. F. Ors, O. Deniz, U. Bozlar, S. Gumus, M. Tasar, E. Tozkoparan, C. Tayfun, H. Bilgic, B. J. Grant, High-resolution CT findings in patients with pulmonary tuberculosis: Correlation with the degree of smear positivity. J. Thorac. Imaging 22, 154-159 (2007).
28. M. Nakanishi, Y. Demura, S. Ameshima, N. Kosaka, Y. Chiba, S. Nishikawa, H. Itoh, T. Ishizaki, Utility of high-resolution computed tomography for predicting risk of sputum smear-negative pulmonary tuberculosis. Eur. J. Radiol. 73, 545-550 (2010).
29. J. J. Yeh, J. K. Yu, W. B. Teng, C. H. Chou, S. P. Hsieh, T. L. Lee, M. T. Wu, High-resolution CT for identify patients with smear-positive, active pulmonary tuberculosis. Eur. J. Radiol. 81, 195-201 (2012).
30. C. Poey, F. Verhaegen, J. Giron, J. Lavayssiere, P. Fajadet, B. Duparc, High resolution chest CT in tuberculosis: Evolutive patterns and signs of activity. J. Comput. Assist. Tomogr. 21, 601-607 (1997).
31. J. J. Lee, P. Y. Chong, C. B. Lin, A. H. Hsu, C. C. Lee, High resolution chest CT in patients with pulmonary tuberculosis: Characteristic findings before and after antituberculous therapy. Eur. J. Radiol. 67, 100-104 (2008).
32. M. W. Carroll, D. Jeon, J. M. Mountz, J. D. Lee, Y. J. Jeong, N. Zia, M. Lee, J. Lee, L. E. Via, S. Lee, S. Y. Eum, S. J. Lee, L. C. Goldfeder, Y. Cai, B. Jin, Y. Kim, T. Oh, R. Y. Chen, L. E. Dodd, W. Gu, V. Dartois, S. K. Park, C. T. Kim, C. E. Barry III, S. N. Cho, Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis. Antimicrob. Agents Chemother. 57, 3903-3909 (2013).
33. O. N. Hatipoglu, E. Osma, M. Manisali, E. S. Ucan, P. Balci, A. Akkoclu, O. Akpinar, C. Karlikaya, C. Yuksel, High resolution computed tomographic findings in pulmonary tuberculosis. Thorax 51, 397-402 (1996).
34. M. Casarini, F. Ameglio, L. Alemanno, P. Zangrilli, P. Mattia, G. Paone, A. Bisetti, S. Giosuè, Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 159, 143-148 (1999).
35. J. Maertzdorf, J. Weiner III, S. H. Kaufmann, Enabling biomarkers for tuberculosis control. Int. J. Tuberc. Lung Dis. 16, 1140-1148 (2012).
36. R. S. Wallis, M. Pai, D. Menzies, T. M. Doherty, G. Walzl, M. D. Perkins, A. Zumla, Biomarkers and diagnostics for tuberculosis: Progress, needs, and translation into practice. Lancet 375, 1920-1937 (2010).
37. R. S. Wallis, C. Wang, T. M. Doherty, P. Onyebujoh, M. Vahedi, H. Laang, O. Olesen, S. Parida, A. Zumla, Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis. 10, 68-69 (2010).
38. A. McErlean, D. M. Panicek, E. C. Zabor, C. S. Moskowitz, R. Bitar, R. J. Motzer, H. Hricak, M. S. Ginsberg, Intra- and interobserver variability in CT measurements in oncology. Radiology 269, 451-459 (2013).
39. J. J. Erasmus, G. W. Gladish, L. Broemeling, B. S. Sabloff, M. T. Truong, R. S. Herbst, R. F. Munden, Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: Implications for assessment of tumor response. J. Clin. Oncol. 21, 2574-2582 (2003).
40. K. D. Hopper, C. J. Kasales, M. A. Van Slyke, T. A. Schwartz, T. R. TenHave, J. A. Jozefiak, Analysis of interobserver and intraobserver variability in CT tumor measurements. AJR Am. J. Roentgenol. 167, 851-854 (1996).
41. C. Parmar, E. Rios Velazquez, R. Leijenaar, M. Jermoumi, S. Carvalho, R. H. Mak, S. Mitra, B. U. Shankar, R. Kikinis, B. Haibe-Kains, P. Lambin, H. J. Aerts, Robust radiomics feature quantification using semiautomatic volumetric segmentation. PLOS One 9, e102107 (2014).
42. V. Paidpally, G. Mercier, B. A. Shah, S. Senthamizhchelvan, R. M. Subramaniam, Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors. AJR Am. J. Roentgenol. 202, 406-412 (2014).
43. M. T. Coleman, R. Y. Chen, M. Lee, P. L. Lin, L. E. Dodd, P. Maiello, L. E. Via, Y. Kim, G. Marriner, V. Dartois, C. Scanga, C. Janssen, J. Wang, E. Klein, S. N. Cho, C. E. Barry III, J. L. Flynn, PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis. Sci. Transl. Med. 6, 265ra167 (2014).
44. L. I. Lin, A concordance correlation coefficient to evaluate reproducibility. Biometrics 45, 255-268 (1989).
45. M. S. Pepe, The Statistical Evaluation of Medical Tests for Classification and Prediction (Oxford Univ. Press, Oxford, 2003).
46. T. Wei, corrplot: Visualization of a correlation matrix. R package version 0.71; http://CRAN.R-project.org/package=corrplot.